Sema4 Plans to Relocate its New York Laboratory to Connecticut and Create Over 400 Jobs in the State
Friday, April 06 2018
Cutting-Edge, Health Information Technology Company Picks Connecticut for its Expansion Plans
Hartford, CT - Governor Dannel P. Malloy announced that Sema4, a Mount Sinai venture providing advanced genomic testing, is planning grow its presence in Connecticut by adding 408 new jobs over the next five years. The health information technology company is moving forward with expansions at its two existing locations in the state, including its recently announced headquarters at 333 Ludlow Street in Stamford and its laboratory at 1 Commercial Street in Branford. In addition, the company will soon be relocating laboratory facilities from New York City to a yet-to-be-determined site in Stamford. The move will bring the company’s job presence in Connecticut to at least 553 employees.
“We are thrilled that Sema4 has chosen to significantly expand its operations in Connecticut, bringing their total workforce to over 550,” Governor Malloy said. “It’s no surprise that this cutting-edge, health information company has decided to grow here, thanks to our first-class talent pipeline and exceptional educational institutions. Today’s announcement isn’t just about economic development, it’s about a vision we began years ago to turn Connecticut into a hub for bioscience and tech growth. Thanks to our targeted investments, that vision is coming to life.”
Sema4, a patient-centered predictive health company, is founded on the idea that more data, deeper analysis, and increased engagement with patients will improve the diagnosis, treatment, and prevention of disease. The company offers advanced genome-based diagnostics for reproductive health and oncology and is building predictive models of complex disease.
“Connecticut offers a very attractive environment for our company to grow along the talent-rich biotech corridor running from New York City to New Haven, with a stellar pool of qualified candidates, plus competitively-priced commercial real estate and the presence of leading universities and medical centers,” Eric Schadt, PhD, founder and CEO of Sema4, said. “We greatly appreciate the strong support from the State of Connecticut to foster our growth, which has facilitated the establishment of our corporate headquarters and accelerated the expansion of our laboratory operations here in Stamford.”
The Department of Economic and Community Development (DECD) will provide a $6 million loan that will be utilized for the purchase of machinery and equipment, capital improvements, and the creation of 408 jobs in Connecticut. The company is eligible for partial loan forgiveness if certain milestones are met. In December 2015, DECD provided the company a $9.5 million loan to create 145 jobs in the state.
“Sema4’s decision to move its New York City lab operations to Connecticut is evidence that this is a great place to grow a business,” Department of Economic and Community Development Commissioner Catherine Smith said. “We are thrilled with Sema4’s decision to relocate its primary diagnostic testing laboratory from New York City and add to the community of bioscience firms in the state."